EP1261736A4 - Methodes et materiaux associes a des polypeptides et des polynucleotides du type facteur-1 des preadipocytes (du type pref-1) - Google Patents

Methodes et materiaux associes a des polypeptides et des polynucleotides du type facteur-1 des preadipocytes (du type pref-1)

Info

Publication number
EP1261736A4
EP1261736A4 EP01906704A EP01906704A EP1261736A4 EP 1261736 A4 EP1261736 A4 EP 1261736A4 EP 01906704 A EP01906704 A EP 01906704A EP 01906704 A EP01906704 A EP 01906704A EP 1261736 A4 EP1261736 A4 EP 1261736A4
Authority
EP
European Patent Office
Prior art keywords
pref
polynucleotides
polypeptides
methods
materials relating
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP01906704A
Other languages
German (de)
English (en)
Other versions
EP1261736A2 (fr
Inventor
Chiauyun Kuo
Dana A Haley
Bryan J Boyle
Matthew C Arterburn
Y Tom Tang
Chenghua Liu
Radoje A Drmanac
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nuvelo Inc
Original Assignee
Nuvelo Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nuvelo Inc filed Critical Nuvelo Inc
Publication of EP1261736A2 publication Critical patent/EP1261736A2/fr
Publication of EP1261736A4 publication Critical patent/EP1261736A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Emergency Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Neurology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Endocrinology (AREA)
  • Cell Biology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
EP01906704A 2000-01-25 2001-01-25 Methodes et materiaux associes a des polypeptides et des polynucleotides du type facteur-1 des preadipocytes (du type pref-1) Withdrawn EP1261736A4 (fr)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US49140400A 2000-01-25 2000-01-25
US491404 2000-01-25
US65100800A 2000-08-29 2000-08-29
US651008 2000-08-29
PCT/US2001/002611 WO2001057233A2 (fr) 2000-01-25 2001-01-25 Methodes et materiaux associes a des polypeptides et des polynucleotides du type facteur-1 des preadipocytes (du type pref-1)

Publications (2)

Publication Number Publication Date
EP1261736A2 EP1261736A2 (fr) 2002-12-04
EP1261736A4 true EP1261736A4 (fr) 2004-12-29

Family

ID=27050422

Family Applications (1)

Application Number Title Priority Date Filing Date
EP01906704A Withdrawn EP1261736A4 (fr) 2000-01-25 2001-01-25 Methodes et materiaux associes a des polypeptides et des polynucleotides du type facteur-1 des preadipocytes (du type pref-1)

Country Status (5)

Country Link
EP (1) EP1261736A4 (fr)
JP (1) JP2003521928A (fr)
AU (1) AU2001234582A1 (fr)
CA (1) CA2398215A1 (fr)
WO (1) WO2001057233A2 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003302757A1 (en) * 2002-12-27 2004-08-10 Laboratoires Serono Sa Novel preadipocyte factor-1-like polypeptides
KR20080105048A (ko) * 2006-03-09 2008-12-03 옴 파르마 면역조절 화합물 및 염증성 사이토킨의 과생성에 관련된 질병의 치료

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001034768A2 (fr) * 1999-11-09 2001-05-17 Human Genome Sciences, Inc. 15 proteines secretees humaines
WO2001066690A2 (fr) * 2000-03-06 2001-09-13 Smithkline Beecham Corporation Nouveaux composes

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001034768A2 (fr) * 1999-11-09 2001-05-17 Human Genome Sciences, Inc. 15 proteines secretees humaines
WO2001066690A2 (fr) * 2000-03-06 2001-09-13 Smithkline Beecham Corporation Nouveaux composes

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
DATABASE EMBL EBI; 12 July 1999 (1999-07-12), NCI-CGAP: "nr33c08.x5 NCI_CGAP_Pr22 Homo sapiens cDNA clone IMAGE:1169774 3' similar to TR:Q25059 Q25059 FIBROPELLIN III ;, mRNA sequence.", XP002303947, Database accession no. AI821806 *
See also references of WO0157233A3 *

Also Published As

Publication number Publication date
WO2001057233A3 (fr) 2002-03-07
EP1261736A2 (fr) 2002-12-04
WO2001057233A2 (fr) 2001-08-09
CA2398215A1 (fr) 2001-08-09
AU2001234582A1 (en) 2001-08-14
JP2003521928A (ja) 2003-07-22

Similar Documents

Publication Publication Date Title
AUPQ976800A0 (en) Novel polypeptides and polynucleotides and uses therefor
EP1250346A4 (fr) Procedes et elements ayant trait a des polypeptides et des polynucleotides de type recepteurs couples a une proteine g
IL153568A (en) Novel polypeptides and polynucleotides
EP1252333A4 (fr) Procedes et substances relatifs a des polypeptides de type cd84 et a des polynucleotides
EP1254266A4 (fr) Methodes et materiaux en rapport avec des polypeptides et de polynucleotides de type alpha-2-macroglobuline
EP1409661A4 (fr) Polypeptides d'hdac9, polynucleotides et leurs utilisations
AU3300301A (en) Methods and materials relating to leukocyte immunoglobulin receptor-like (lir-like) polypeptides and polynucleotides
EP1254269A4 (fr) Procedes et matieres lies aux polypeptides et aux polynucleotides du type molecule de guidage neuronal (du type ngm)
EP1261736A4 (fr) Methodes et materiaux associes a des polypeptides et des polynucleotides du type facteur-1 des preadipocytes (du type pref-1)
AU3486501A (en) Methods and materials relating to alpha-2-macroglobulin-like polypeptides and polynucleotides
AU2002360460A8 (en) Methods and materials relating to novel polypeptides and polynucleotides
EP1254265A4 (fr) Methodes et materiaux concernant des polypeptides et des polynucleotides du type metallocarboxypeptidase
EP1240178A4 (fr) Procedes et substances relatifs a des polypeptides de type prothrombinase et a des polynucleotides
EP1365801A4 (fr) Methodes et materiels se rapportant a des polypeptides et a des polynucleotides apparentes a la fibuline
AU2002359351A8 (en) Methods and materials relating to prokineticin-like polypeptides and polynucleotides
EP1276902A4 (fr) Procedes et substances relatifs a des polypeptides de type antigene carcino-embryonnaire (cea) et a des polynucleotides
EP1409715A4 (fr) Procedes et materiaux concernant des polypeptides et des polynucleotides du type neurotrimin
GB0031021D0 (en) Polynucleotides and polypeptides
AU2001231288A1 (en) Methods and materials relating to matrix metalloprotease-like polypeptides and polynucleotides
AUPQ645700A0 (en) Novel polypeptides and polynucleotides and methods of using them
AU2001289027A1 (en) Methods and materials relating to neuropilin-like polypeptides and polynucleotides
EP1242580A4 (fr) Procedes et substances relatifs a des polypeptides de type semaphorine et a des polynucleotides
AU2001294267A1 (en) Survivin-like polypeptides and dnas thereof
AU2001232967A1 (en) Methods and materials relating to novel growth regulatory-like polypeptides and polynucleotides
GB0112941D0 (en) Sbg FGF-9A Polynucleotides and polypeptides

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20020826

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR

AX Request for extension of the european patent

Free format text: AL;LT;LV;MK;RO;SI

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: NUVELO INC.

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: NUVELO, INC.

A4 Supplementary search report drawn up and despatched

Effective date: 20041116

RIC1 Information provided on ipc code assigned before grant

Ipc: 7C 07K 14/00 B

Ipc: 7C 07H 21/02 B

Ipc: 7C 12Q 1/68 A

Ipc: 7C 07K 14/705 B

17Q First examination report despatched

Effective date: 20050225

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20051108